Kissei Pharmaceutical Co Ltd
TSE:4547
Net Margin
Kissei Pharmaceutical Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
|
Kissei Pharmaceutical Co Ltd
TSE:4547
|
155B JPY |
14%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
680.7B USD |
24%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
362.5B USD |
16%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
35%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
196.2B CHF |
20%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
176.4B CHF |
23%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
204.8B USD |
27%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
155.9B GBP |
13%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
128.2B USD |
13%
|
Kissei Pharmaceutical Co Ltd
Glance View
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. The company is headquartered in Matsumoto-Shi, Nagano-Ken and currently employs 1,863 full-time employees. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The firm is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. The company is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Kissei Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 14%.
You don't have any saved screeners yet